openPR Logo
Press release

Ioversol Market - Global Industry Insights and Opportunity Analysis, 2017–2025

10-09-2017 04:11 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Ioversol Market - Global Industry Insights and Opportunity

Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic (x-ray) examination. Ioversol is injected into an artery or vein through an IV (Intravenous). The uniqueness and versatility of ioversol has also expanded its use in magnetic resonance imaging and ultrasound scattering. Ioversol is also used for the treatment, control, prevention and improvement of heart disorders, brain disorders and blood vessel disorders. Ioversol is generally not given on dosage. However, in some cases, a dosage of ioversol is given to the patient based on the condition he/she is being treated, how patient respond to this drug, patient’s weight, height, age, and gender, etc. CMI predicts the global Ioversal market to grow at a healthy growth rate over the forecast period owing to an escalating demand for ioversol among consumers and clinics.

The market for ioversol is mainly driven by the robustly growing imaging and x-ray market. Rising prevalence of cardiovascular disorders is giving pace to x-ray industry and thus the ioversol market. Bone-related challenges and diseases, rising accidents and kidney related problems are the key drivers for growth of the ioversol industry. Another factor boosting growth of the global ioversol market is the growing geriatric population which are more prone to orthopedic disorders than the younger demographics. However, factors such as allergic reaction by use of ioversol, swelling, difficulty in breathing, rapid weight gain, joint pain or stiffness, muscle pain or weakness, nausea, sweating, etc. may hamper the demand for ioversol in the near future. Advancements in the computed tomography (CT) technology can prove to be a lucrative factor for market growth over the forecast period.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/386

Ioversol Market Taxonomy

Based on the type, the global Ioversol market is segmented into the following:

-Ioversol 34% Injectable Solution (Optiray 160)
-Ioversol 51% Injectable Solution (Optiray 240)
-Ioversol 64% Injectable Solution (Optiray 300)
-Ioversol 68% Injectable Solution (Optiray 320)
-Ioversol 74% Injectable Solution (Optiray 350)

Based on packaging, the market is segmented into:

-Vials
-Bottles
-Hand-held syringes
-Power-injector syringes

Ioversol 64% Injectable Solution, made from 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of calcium disodium as a stabilizer, is the most commonly used ioversol type primarily owing to high scope of application, ease of use and low cost. On the basis of application, the x-ray segment is forecast to grow at the fastest rate over the forecast period owing to the growing demand for ioversol in angiography, tomography, urography and others.

Market Outlook - Asia Pacific is expected to be the most lucrative region for the key players operating in the global Ioversol market

On the basis of geography, the global ioversol market is segmented into North America, Latin America, Europe, Middle East, Asia-Pacific and Africa. Market of Ioversol is anticipated to witness a high demand in the Asia-Pacific region owing to the constant rise in pharmaceutical spending, increasing awareness regarding the use of ioversol and the growing population base, particularly in countries such as China and India. North America is currently the second largest market for ioversol and is expected to grow at an above average growth rate over the forecast period. Europe is expected to showcase a sluggish growth during the forecast period owing to the maturing pharmaceutical industry.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/ioversol-market-386

The key players profiled in the global ioversol market are Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co., Mallinckrodt Pharmaceuticals, Ultraject, China Resources Pharmaceutical Co., HB Ocean, Changzhou Highassay Chemical Co., Ltd., and various others. Major players in the market are focused on product launches and organic growth by means of mergers and acquisitions.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ioversol Market - Global Industry Insights and Opportunity Analysis, 2017–2025 here

News-ID: 763596 • Views: 306

More Releases from Pharmaceutical Report By CMI

Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the

All 5 Releases


More Releases for Ioversol

Ioversol Global Industry Report - History, Present and Future 2025
The global market size of Ioversol is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Ioversol Market Opportunity Analysis, 2018–2026
Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic
Ioversol Market - Global Industry Insights, 2017–2025
Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic
Ioversol Market | Global Insights 2017–2025
Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to absorb x-rays. Ioversol allows the blood vessels, organs and others non-bony tissues of the body to be seen more clearly during a CT scan or similar radiologic
Ioversol Market Size 2017-2022 Ultraject, Guerbet, Mallinckrodt Pharmaceuticals
Ioversol market research 2017 Global market study " Ioversol Market Size 2017-2022 " analyses the crucial factors of the Ioversol market based on present industry situations, market demands, business strategies adopted by Ioversol market players and their growth scenario. This report isolates the Ioversol market based on the key players, Type, Application and Regions. The Ioversol report provides the past, present and future Ioversol industry Size, trends and the forecast information